Stay updated on Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Sign up to get notified when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page

  1. Check
    today
    No Change Detected
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.15.0 to version 2.15.2.
    Difference
    0.1%
    Check dated 2025-05-01T06:20:35.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The webpage has undergone significant updates, including the removal of detailed descriptions of a phase II trial for urothelial carcinoma and the addition of new identifiers and a location for the study. The revision number has also been updated.
    Difference
    39%
    Check dated 2025-04-16T20:34:17.000Z thumbnail image
  5. Check
    29 days ago
    Change Detected
    Summary
    The web page has been updated from version 2.14.3 to version 2.14.4.
    Difference
    0.1%
    Check dated 2025-04-09T14:42:01.000Z thumbnail image
  6. Check
    73 days ago
    Change Detected
    Summary
    The page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.
    Difference
    2%
    Check dated 2025-02-24T23:06:03.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The page now includes a notice about heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.
    Difference
    2%
    Check dated 2025-02-10T16:41:26.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    The website has been updated from version v2.14.1 to v2.14.2.
    Difference
    0.1%
    Check dated 2025-02-03T11:42:49.000Z thumbnail image

Stay in the know with updates to Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab+Ipilimumab+Radiation in MSS/MSI-High CRC/Pancreatic Clinical Trial page.